Related references
Note: Only part of the references are listed.Comparison of Transcriptional and Blood Cell-Phenotypic Markers Between Operationally Tolerant Liver and Kidney Recipients
J. J. Lozano et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Influence of CIT-Induced DGF on Kidney Transplant Outcomes
L. K. Kayler et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
The APOL1 Gene and Allograft Survival after Kidney Transplantation
A. M. Reeves-Daniel et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Population-Based Risk Assessment of APOL1 on Renal Disease
David J. Friedman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Desensitization in HLA-Incompatible Kidney Recipients and Survival
Robert A. Montgomery et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Phase III Study of Belatacept-based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
F. Vincenti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Identification of a B cell signature associated with renal transplant tolerance in humans
Kenneth A. Newell et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Deceased-donor characteristics and the survival benefit of kidney transplantation
RM Merion et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-lg with potent immunosuppressive properties
CP Larsen et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)